Summary
Background
The classic symptom of peripheral arterial disease is the intermittent claudication (IC). Generally, endurance training is recommended to improve patients’ walking performance. A potential benefit of the combination with strength training and the optimal duration of such an exercise program remain unclear.
Methods and results
We evaluated the effects of a supervised exercise program combining endurance and strength training lasting 6 or 12 months in patients with IC. A total of 94 patients joined this study; 42 completed the 6-month training program (group A), whereas 52 patients completed the 12-month protocol (group B). Both groups exhibited a significant increase in all parameters evaluated, but greater benefit was found in the 12-month training group. The absolute claudication distance increased similarly by 27.5 and 29.5 %, respectively, in both groups (not significant); however, group B exhibited a greater increase in walking speed (12.1 vs. 5.3 %, p < 0.001). All strength parameters increased significantly in both the groups showing an increase for “pushing” by 90.0 % (group A) and 90.2 % (group B), for “pulling” by 64.2 % (group A) and 75.3 % (group B), and for “tiptoe standing” by 70.5 % (group A) and 113.7 % (group B; p < 0.05).
Conclusion
The results of this study indicate that a combined exercise program significantly increases walking speed, absolute claudication distance, and muscle strength parameters. A greater benefit seems to result from a 12-month training program.
Zusammenfassung
Hintergrund
Das klassische Symptom der peripheren arteriellen Verschlusskrankheit ist die Claudicatio intermittens (CI). Im Allgemeinen wird ein Ausdauertraining empfohlen, um die Gehleistung der Patienten zu verbessern. Ein möglicher Nutzen einer Kombination mit Krafttraining und die optimale Dauer solcher Trainingsprogramme sind aber unklar.
Methoden und Ergebnisse
Wir evaluierten den Effekt eines sechs beziehungsweise 12 Monate dauernden überwachten Trainingsprogrammes, in dem Kraft- und Ausdauertraining kombiniert waren, auf Patienten mit CI. 94 Patienten nahmen an dieser Studie teil, 42 absolvierten das 6-Monate-Trainingsprogramm (Gruppe A), 52 das 12-Monate-Trainingsprogramm (Gruppe B). In beiden Gruppen zeigte sich ein signifikanter Anstieg in den evaluierten Parametern, wobei ein größerer Nutzen in der 12-Monats-Gruppe gefunden wurde. Die absolute Claudicatio-Strecke stieg gleichermaßen um 27,5 % beziehungsweisen 29,5 % in beiden Gruppen (n.s.), wobei Gruppe B einen größeren Anstieg in der Gehgeschwindigkeit aufwies (12,1 % vs. 5,3 %, p < 0,001). Alle Kraftparameter stiegen signifikant in beiden Gruppen an und zeigten einen Anstieg beim „Drücken“ um 90,0 % (Gruppe A) beziehungsweise 90,2 % (Gruppe B), für „Ziehen“ 64,2 % beziehungsweise 75,3 % und bei den „Zehenspitzenständen“ um 70,5 % beziehungsweise 113,7 % (A vs. B, p < 0,05).
Schlussfolgerung
Die Ergebnisse dieser Studie zeigen, dass die Kombination von Kraft- und Ausdauertraining signifikant die Gehgeschwindigkeit, die absolute Claudicatio-Strecke und die Kraft-Parameter erhöhen. Das 12-Monate-Trainingsprogramm scheint dabei einen größeren Nutzen zu erzielen.
Similar content being viewed by others
References
Cooke JP, Wilson AM. Biomarkers of peripheral arterial disease. J Am Coll Cardiol. 2010;55(19):2017–23.
King S, Vanicek N, Mockford KA, Coughlin PA. The effect of a 3-month supervised exercise programme on gait parameters of patients with peripheral arterial disease and intermittent claudication. Clin Biomech. 2012;27(8):845–51.
Nelson MR, Quinn S, Winzenberg TM, Howes F, Shiel L, Reid CM. Ankle-Brachial Index determination and peripheral arterial disease diagnosis by an oscillometric blood pressure device in primary care: validation and diagnostic accuracy study. BMJ Open. 2012;2(5):e001689.
Guidon M, McGee H. One-year effect of a supervised exercise programme on functional capacity and quality of life in peripheral arterial disease. Disabil Rehabil. 2013;35(5):397–404.
Van Asselt AD, Nicolaï SP, Joore MA, Prins MH, Teijink JA. Cost-effectiveness of exercise therapy in patients with intermittent claudication: supervised exercise therapy versus a ‘go home and walk’ advice. Exercise Therapy in Peripheral Arterial Disease Study Group. Eur J Vasc Endovasc Surg. 2011;41(1):97–103.
McDermott MM, Greenland P, Liu K, et al. Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment. JAMA. 2001;286(13):1599–606.
Osinbowale OO, Milani RV. Benefits of exercise therapy in peripheral arterial disease. Prog Cardiovasc Dis. 2011;53(6):447–53.
Abdulhannan P, Russell DA, Homer-Vanniasinkam S. Peripheral arterial disease: a literature review. Br Med Bull. 2012;104:21–39.
Stewart KJ, Hiatt WR, Regensteiner JG, Hirsch AT. Exercise training for claudication. N Engl J Med. 2002;347(24):1941–51.
Cousin A, Popielarz S, Wieczorek V, Tiffreau V, Mounier-Vehier C, Thevenon A. Impact of a rehabilitation program on muscular strength and endurance in peripheral arterial occlusive disease patients. Ann Phys Rehabil Med. 2011;54(7):429–42.
Norgren L, Hiatt WR, Dormandy JA, et al., TASC II Working Group. Inter-society consensus for the management of peripheral arterial disease. Int Angiol. 2007;26(2):81–157.
Murphy TP, Cutlip DE, Regensteiner JG, et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six-month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation. 2012;125(1):130–9.
Spronk S, Bosch JL, den Hoed PT, Veen HF, Pattynama PM, Hunink MG. Intermittent claudication: clinical effectiveness of endovascular revascularization versus supervised hospital-based exercise training—randomized controlled trial. Radiology. 2009;250(2):586–95.
Wang E, Hoff J, Loe H, Kaehler N, Helgerud J. Plantar flexion: an effective training for peripheral arterial disease. Eur J Appl Physiol. 2008;104(4):749–56.
Wang E, Helgerud J, Loe H, Indseth K, Kaehler N, Hoff J. Maximal strength training improves walking performance in peripheral arterial disease patients. Scand J Med Sci Sports. 2010;20(5):764–70.
Mosti MP, Wang E, Wiggen ØN, Helgerud J, Hoff J. Concurrent strength and endurance training improves physical capacity in patients with peripheral arterial disease. Scand J Med Sci Sports. 2011;21(6):308–14.
Häkkinen K, Alen M, Kraemer WJ, et al. Neuromuscular adaptations during concurrent strength and endurance training versus strength training. Eur J Appl Physiol. 2003;89(1):42–52.
Kraemer WJ, Patton JF, Gordon SE, et al. Compatibility of high-intensity strength and endurance training on hormonal and skeletal muscle adaptations. J Appl Physiol. 1995;78(3):976–89.
Bell GJ, Syrotuik D, Martin TP, Burnham R, Quinney HA. Effect of concurrent strength and endurance training on skeletal muscle properties and hormone concentrations in humans. Eur J Appl Physiol. 2000;81(5):418–27.
European Stroke Organisation, Tendera M, Aboyans V, Bartelink ML, et al. ESC guidelines on the diagnosis and treatment of peripheral artery diseases: document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J. 2011;32:2851–906.
Simmons A, Steffen K, Sanders S. Medical therapy for peripheral arterial disease. Curr Opin Cardiol. 2012;27(6):592–7.
Watson L, Ellis B, Leng GC. Exercise for intermittent claudication. Cochrane Database Syst Rev. 2008;(4):CD000990.
Thomas DR. Managing peripheral arterial disease and vascular ulcers. Clin Geriatr Med. 2013;29(2):425–31.
Lauret GJ, van Dalen DC, Willigendael EM, et al. Supervised exercise therapy for intermittent claudication: current status and future perspectives. Vascular. 2012;20(1):12–9.
Kruidenier LM, Viechtbauer W, Nicolaï SP, Büller H, Prins MH, Teijink JA. Treatment for intermittent claudication and the effects on walking distance and quality of life. Vascular. 2012;20(1):20–35.
Nicolaï SP, Hendriks EJ, Prins MH, Teijink JA, EXITPAD study group. Optimizing supervised exercise therapy for patients with intermittent claudication. J Vasc Surg. 2010;52(5):1226–33.
Bendermacher BL, Kruidenier LM, Nicolaï SP, Welten RJ, Teijink JA. Supervised exercise therapy for intermittent claudication. Acta Chir Belg. 2007;107(6):616–22.
Le Faucheur A, Abraham P, Jaquinandi V, Bouyé P, Saumet JL, Noury-Desvaux B. Measurement of walking distance and speed in patients with peripheral arterial disease: a novel method using a global positioning system. Circulation. 2008;117(7):897–904.
Kruidenier LM, Nicolaï SP, Hendriks EJ, Bollen EC, Prins MH, Teijink JA. Supervised exercise therapy for intermittent claudication in daily practice. J Vasc Surg. 2009;49(2):263–70.
McDermott MM, Ades PA, Dyer A, Guralnik JM, Kibbe M, Criqui MH. Corridor-based functional performance measures correlate better with physical activity during daily life than treadmill measures in persons with peripheral arterial disease. J Vasc Surg. 2008;48(5):1231–7.
Greig C, Butler F, Skelton D, Mahmud S, Young A. Treadmill walking in old age may not reproduce the real life situation. J Am Geriatr Soc. 1993;41(1):15–8.
Regensteiner JG, Wolfel EE, Brass EP, et al. Chronic changes in skeletal muscle histology and function in peripheral arterial disease. Circulation. 1993;87(2):413–21.
Gerdle B, Hedberg B, Angquist KA, Fugl-Meyer AR. Isokinetic strength and endurance in peripheral arterial insufficiency with intermittent claudication. Scand J Rehabil Med. 1986;18(1):9–15.
McDermott MM, Tian L, Ferrucci L, et al. Associations between lower extremity ischemia, upper and lower extremity strength, and functional impairment with peripheral arterial disease. J Am Geriatr Soc. 2008;56(4):724–9.
McDermott MM, Hoff F, Ferrucci L, et al. Lower extremity ischemia, calf skeletal muscle characteristics, and functional impairment in peripheral arterial disease. J Am Geriatr Soc. 2007;55(3):400–6.
Hiatt WR, Wolfel EE, Meier RH, Regensteiner JG. Superiority of treadmill walking exercise versus strength training for patients with peripheral arterial disease. Implications for the mechanism of the training response. Circulation. 1994;90(4):1866–74.
Marzolini S, Oh PI, Thomas SG, et al. Aerobic and resistance training in coronary disease: single versus multiple sets. Med Sci Sports Exerc. 2008;40:1557–64.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pilz, M., Kandioler-Honetz, E., Wenkstetten-Holub, A. et al. Evaluation of 6- and 12-month supervised exercise training on strength and endurance parameters in patients with peripheral arterial disease. Wien Klin Wochenschr 126, 383–389 (2014). https://doi.org/10.1007/s00508-014-0548-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00508-014-0548-y
Keywords
- Peripheral arterial disease
- Intermittent claudication
- Supervised exercise program
- Endurance training
- Strength training